Benign prostatic hyperplasia pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 2: Line 2:
{{Benign prostatic hyperplasia}}
{{Benign prostatic hyperplasia}}
{{SCC}}
{{SCC}}
==Overview==
==Pathophysiology==
==Pathophysiology==
[[Androgen]]s ([[testosterone]] and related [[hormone]]s) are considered to play a permissive role in [[BPH]] by most experts. This means that [[androgen]]s have to be present for BPH to occur, but do not necessarily directly cause the condition. This is supported by the fact that [[castration|castrated]] boys do not develop BPH when they age, unlike intact men. Additionally, administering exogenous testosterone is not associated with a significant increase in the risk of BPH symptoms. [[Dihydrotestosterone]] ([[DHT]]), a [[metabolite]] of testosterone is a critical mediator of prostatic growth. DHT is synthesized in the prostate from circulating testosterone by the action of the enzyme 5α-reductase, type 2. This enzyme is localized principally in the stromal cells; hence, these cells are the main site for the synthesis of [[DHT]].   
[[Androgen]]s ([[testosterone]] and related [[hormone]]s) are considered to play a permissive role in [[BPH]] by most experts. This means that [[androgen]]s have to be present for BPH to occur, but do not necessarily directly cause the condition. This is supported by the fact that [[castration|castrated]] boys do not develop BPH when they age, unlike intact men. Additionally, administering exogenous testosterone is not associated with a significant increase in the risk of BPH symptoms. [[Dihydrotestosterone]] ([[DHT]]), a [[metabolite]] of testosterone is a critical mediator of prostatic growth. DHT is synthesized in the prostate from circulating testosterone by the action of the enzyme 5α-reductase, type 2. This enzyme is localized principally in the stromal cells; hence, these cells are the main site for the synthesis of [[DHT]].   
Line 23: Line 20:
[[Category:Andrology]]
[[Category:Andrology]]
[[Category:Urology]]
[[Category:Urology]]
[[Category:Surgery]]
[[Category:Primary care]]
[[Category:Disease]]
[[Category:Needs overview]]

Revision as of 19:59, 26 March 2013

Benign prostatic hyperplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Benign Prostatic Hyperplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Benign prostatic hyperplasia pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Benign prostatic hyperplasia pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Benign prostatic hyperplasia pathophysiology

CDC on Benign prostatic hyperplasia pathophysiology

Benign prostatic hyperplasia pathophysiology in the news

Blogs on Benign prostatic hyperplasia pathophysiology

Directions to Hospitals Treating Benign prostatic hyperplasia

Risk calculators and risk factors for Benign prostatic hyperplasia pathophysiology

Steven C. Campbell, M.D., Ph.D.

Pathophysiology

Androgens (testosterone and related hormones) are considered to play a permissive role in BPH by most experts. This means that androgens have to be present for BPH to occur, but do not necessarily directly cause the condition. This is supported by the fact that castrated boys do not develop BPH when they age, unlike intact men. Additionally, administering exogenous testosterone is not associated with a significant increase in the risk of BPH symptoms. Dihydrotestosterone (DHT), a metabolite of testosterone is a critical mediator of prostatic growth. DHT is synthesized in the prostate from circulating testosterone by the action of the enzyme 5α-reductase, type 2. This enzyme is localized principally in the stromal cells; hence, these cells are the main site for the synthesis of DHT.

DHT can act in an autocrine fashion on the stromal cells or in paracrine fashion by diffusing into nearby epithelial cells. In both of these cell types, DHT binds to nuclear androgen receptors and signals the transcription of growth factors that are mitogenic to the epithelial and stromal cells. DHT is 10 times more potent than testosterone because it dissociates from the androgen receptor more slowly. The importance of DHT in causing nodular hyperplasia is supported by clinical observations in which an inhibitor of 5α-reductase is given to men with this condition. Therapy with 5α-reductase inhibitor markedly reduces the DHT content of the prostate and in turn reduces prostate volume and, in many cases, BPH symptoms.

There is growing evidence that estrogens play a role in the etiology of BPH. This is based on the fact that BPH occurs when men generally have elevated estrogen levels and relatively reduced free testosterone levels, and when prostate tissue becomes more sensitive to estrogens and less responsive to DHT. Cells taken from the prostates of men who have BPH have been shown to grow in response to high estradiol levels with low androgens present. Estrogens may render cells more susceptible to the action of DHT.

On a microscopic level, BPH can be seen in the vast majority of men as they age, particularly over the age of 70 years, around the world. However, rates of clinically significant, symptomatic BPH vary dramatically depending on lifestyle. Men who lead a western lifestyle have a much higher incidence of symptomatic BPH than men who lead a traditional or rural lifestyle. This is confirmed by research in China showing that men in rural areas have very low rates of clinical BPH, while men living in cities adopting a western lifestyle have a skyrocketing incidence of this condition, though it is still below rates seen in the West.

Much work remains to be done to completely clarify the causes of BPH.

References

Template:WH Template:WS